NEI
AUPH icon

Northwest & Ethical Investments’s Aurinia Pharmaceuticals AUPH Stock Holding History

Northwest & Ethical Investments’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-13,263
Closed -$172K – 402
2021
Q2 		$172K Buy
13,263
+8,869
+202% +$113K 0.01% 378
2021
Q1 		$57.1K Buy
4,394
+511
+13% +$7.41K ﹤0.01% 389
2020
Q4 		$53.6K Buy
3,883
+390
+11% +$5.68K ﹤0.01% 391
2020
Q3 		$51.4K Sell
3,493
-3,628
-51% -$52.6K ﹤0.01% 382
2020
Q2 		$116K Buy
+7,121
New +$114K 0.01% 359

Other funds holding AUPH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KPWS
Kestra Private Wealth Services Austin, Texas $8.11B AUM 24.74% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
Voloridge Investment Management
Voloridge Investment Management Jupiter, Florida $25B AUM 28.08% 1-Year Est. Return

Northwest & Ethical Investments's AUPH Position: Q3 2021 in Review

Northwest & Ethical Investments sold out of Aurinia Pharmaceuticals (AUPH) in Q3 2021, closing a stake of 13,263 shares — an estimated $172K sold.

Northwest & Ethical Investments first reported a position in AUPH in Q2 2020 and held it in 5 quarters. The position peaked at $172K in Q2 2021. 166 funds tracked by Wall St. Rank hold AUPH as of Q3 2021.

  • Northwest & Ethical Investments reported no remaining Aurinia Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • Northwest & Ethical Investments sold 13,263 Aurinia Pharmaceuticals shares in Q3 2021, an estimated $172K.
  • Northwest & Ethical Investments first reported a position in Aurinia Pharmaceuticals in Q2 2020 and held it in 5 quarters.
  • Northwest & Ethical Investments's Aurinia Pharmaceuticals position peaked at $172K in Q2 2021.
  • 166 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q3 2021.

Based on Northwest & Ethical Investments's 13F filing for Q3 2021, filed 9 Jul 2025.